Clear, practical articles about medicines, active ingredients, treatment areas, and informed next steps.
521 articles found
Capecitabine is an oral anticancer medicine classified as a fluoropyrimidine antimetabolite. It is a prodrug of 5-fluorouracil (5-FU), meaning the body converts Capecitabine into 5-FU, which interferes with DNA and RNA synthesis in rapidly dividing cancer cells. It is commonly used in the treatment…
Read articleAnastrozole is an oral aromatase inhibitor (AI) and a type of hormonal therapy used primarily in the treatment of hormone receptor-positive (HR+) breast cancer in postmenopausal women. It works by reducing the production of estrogen in the body. Since some breast cancer cells depend on estrogen to g…
Read articleAlectinib is an oral targeted anticancer medicine categorized as an anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor (TKI). It belongs to a modern class of targeted therapies used primarily in the treatment of ALK-positive non-small cell lung cancer (NSCLC). Alectinib works by selectively…
Read articleLenalidomide is an oral targeted therapy categorized as an immunomodulatory drug (IMiD). It belongs to a specialized class of precision medicines used primarily in the management of multiple myeloma and specific subtypes of myelodysplastic syndromes (MDS) and lymphomas. Unlike traditional broad-spec…
Read articleTofacitinib is an oral targeted therapy categorized as a Janus kinase (JAK) inhibitor. It belongs to a modern class of targeted synthetic disease-modifying anti-rheumatic drugs (tsDMARDs) used primarily in the management of moderate-to-severe autoimmune and chronic inflammatory conditions. Unlike tr…
Read articleApremilast is an oral targeted therapy categorized as a selective phosphodiesterase 4 (PDE4) inhibitor. It belongs to a class of disease-modifying anti-rheumatic and immunomodulatory medications used primarily in the management of chronic inflammatory autoimmune conditions. Unlike traditional immuno…
Read articleSorafenib (sold under the brand name Nexavar) is a targeted antineoplastic medication categorized as an oral multikinase inhibitor. It represents a significant milestone in oncology, offering a dual-action targeted mechanism that inhibits both tumor cell proliferation and tumor angiogenesis (the gro…
Read articleGefitinib (sold under the brand name Iressa) is a targeted antineoplastic medication categorized as a first-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). It represents a significant breakthrough in precision oncology, offering targeted oral therapy for specific…
Read articleImatinib (sold under brand names such as Gleevec and Glivec) is a landmark targeted antineoplastic medication categorized as a first-generation tyrosine kinase inhibitor (TKI). It revolutionized modern oncology as one of the first successful examples of precision targeted therapy, transforming once-…
Read articleAbiraterone Acetate (sold under brand names such as Zytiga and Yonsa) is an advanced oral, targeted endocrine therapeutic agent categorized as a CYP17 inhibitor (androgen synthesis inhibitor). It represents a major milestone in urologic oncology, providing an effective treatment option for patients…
Read article
